FR3006466B3
(fr )
2015-10-30
.
BR302014001381S1
(pt )
2015-07-21
Configuração aplicada em bolsa.
DK2970389T3
(da )
2020-10-26
Farmaceutiske forbindelser
DK3043778T3
(da )
2017-11-27
Farmaceutiske sammensætninger, der indeholder refametinib
DK3027249T3
(da )
2022-05-09
Injektionspen
DK3171701T3
(da )
2021-05-03
Infusionsanlæg
BR112016011147A2
(pt )
2017-09-26
autoinjetor
FR3007989B1
(fr )
2016-01-01
Autoinjecteur.
FR3013601B1
(fr )
2017-08-11
Autoinjecteur.
DK2975030T3
(da )
2020-08-31
Dihydropyridazin-3,5-dion-derivat
DK3363428T3
(da )
2024-05-21
Perfusionsdoseringsform
BR112014028921A2
(pt )
2018-05-22
injetor.
DE112014004954T8
(de )
2016-09-08
Abgabesystem
ES2651188T8
(es )
2018-02-12
Composición líquida fotopolimerizable
DE112014004938T8
(de )
2016-09-08
Abgabesystem
FR3001302B1
(fr )
2016-01-22
.
DK3027656T3
(da )
2019-08-05
Medikament, der omfatter anti-phospholipase d4-antistof
DK2983747T3
(da )
2020-02-24
Lægemiddelindgivelsesindretning
FR3001303B1
(fr )
2015-07-31
.
ES1086107Y
(es )
2013-10-24
Contenedor armable.
DE112014002244A5
(de )
2016-01-21
Infusionslösung
DK3035824T3
(da )
2022-09-05
Hylde
TH1401007879A
(th )
2016-07-06
สารละลายอะเซทามิโนเฟนที่ฉีดได้สำหรับการให้ทางไขสันหลัง
UA28329S
(uk )
2014-11-10
Шприц
UA30187S
(uk )
2015-09-10
Ампула